Sign in

CIK 0000882095 · Large accelerated filer

GILEAD SCIENCES, INC.

Sign in to watch
Ticker
GILD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943047598
Phone
6505743000
Business address
333 LAKESIDE DR, FOSTER CITY, CA, 94404
Former names
GILEAD SCIENCES INC
  1. 4 Planned sale Chairman & CEO sold 15,000 shares at an average $130.31 ($1,954,694)
  2. 8-K Event Results of operations
  3. 144 Insider Sale of Securities
  4. 13F-HR Other Quarterly Holdings of Institutional Investment Managers
  5. 4 Planned sale Chief Financial Officer sold 3,000 shares at $129.93 ($389,777)
  6. 4 Planned sale Chief Comm & Corp Aff Officer sold 3,000 shares at $129.92 ($389,758)
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 4 Planned sale Chairman & CEO sold 15,000 shares at an average $126.29 ($1,894,400)
  10. 4 Planned sale Chief Comm & Corp Aff Officer sold 3,000 shares at an average $123.92 ($371,762)
  11. 4 Planned sale Chief Financial Officer sold 3,000 shares at $125.40 ($376,200)
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 4 Shares withheld for taxes Chief Medical Officer gave up 263 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP Gen Counsel, Legal & Comp gave up 283 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 1,341 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Comm & Corp Aff Officer gave up 1,341 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chairman & CEO gave up 4,213 shares (to pay taxes)
  19. 4 Planned sale Chairman & CEO sold 15,000 shares at an average $131.46 ($1,971,847)
  20. 144 Insider Sale of Securities

Page 3 of 160 · 3,186 filings